These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12372545)

  • 21. Diet-induced obesity and cardiovascular regulation in C57BL/6J mice.
    Williams TD; Chambers JB; Roberts LM; Henderson RP; Overton JM
    Clin Exp Pharmacol Physiol; 2003 Oct; 30(10):769-78. PubMed ID: 14516417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perinatal MSG treatment attenuates fasting-induced bradycardia and metabolic suppression.
    Messina MM; Evans SA; Swoap SJ; Overton JM
    Physiol Behav; 2005 Oct; 86(3):324-30. PubMed ID: 16153669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cardiovascular responses to mu opioid agonist and antagonist in conscious normal and obese rats.
    Hill-Pryor C; Lindsey D; Lapanowski K; Dunbar JC
    Peptides; 2006 Jun; 27(6):1520-6. PubMed ID: 16293344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic central nervous system hyperinsulinemia and regulation of arterial pressure and food intake.
    Liu J; da Silva AA; Tallam LS; Hall JE
    J Hypertens; 2006 Jul; 24(7):1391-5. PubMed ID: 16794489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of medial prefrontal cortex neurons in behavioral and cardiovascular responses to contextual fear conditioning.
    Resstel LB; Joca SR; Guimarães FG; Corrêa FM
    Neuroscience; 2006 Dec; 143(2):377-85. PubMed ID: 16973302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sucrose drinking reduces dorsal hypothalamic beta-endorphin levels in spontaneously hypertensive rats but not in Wistar-Kyoto rats.
    Zhang T; Rockhold RW
    Brain Res Bull; 1993; 32(3):261-5. PubMed ID: 8374805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular actions of central neuromedin U in conscious rats.
    Chu C; Jin Q; Kunitake T; Kato K; Nabekura T; Nakazato M; Kangawa K; Kannan H
    Regul Pept; 2002 Apr; 105(1):29-34. PubMed ID: 11853869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of cardiovascular effects of caffeine using telemetric monitoring in the conscious rat.
    Ilbäck NG; Siller M; Stålhandske T
    Food Chem Toxicol; 2007 May; 45(5):834-42. PubMed ID: 17175084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Central actions of corticotropin-releasing hormone (CRH) on behavioral, neuroendocrine, and cardiovascular regulation: brain corticoid receptor involvement.
    Korte SM; Bouws GA; Bohus B
    Horm Behav; 1993 Jun; 27(2):167-83. PubMed ID: 8394279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Male prairie voles display cardiovascular dipping associated with an ultradian activity cycle.
    Lewis R; Curtis JT
    Physiol Behav; 2016 Mar; 156():106-16. PubMed ID: 26780151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A canine model used to simultaneously assess potential neurobehavioural and cardiovascular effects of candidate drugs.
    Tontodonati M; Fasdelli N; Moscardo E; Giarola A; Dorigatti R
    J Pharmacol Toxicol Methods; 2007; 56(2):265-75. PubMed ID: 17587603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous beta-endorphin: behavioral and physiological effects in conscious monkeys.
    Cuthbert BN; Holaday JW; Meyerhoff J; Li CH
    Peptides; 1989; 10(4):729-34. PubMed ID: 2531374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.
    Bunting MW; Widdop RE
    Br J Pharmacol; 1995 Dec; 116(8):3181-90. PubMed ID: 8719794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pressor response to central administration of beta-endorphin results from a centrally mediated increase in noradrenaline release and adrenaline secretion.
    May CN; Whitehead CJ; Mathias CJ
    Br J Pharmacol; 1991 Mar; 102(3):639-44. PubMed ID: 1364832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central leptin infusion attenuates the cardiovascular and metabolic effects of fasting in rats.
    Overton JM; Williams TD; Chambers JB; Rashotte ME
    Hypertension; 2001 Feb; 37(2 Pt 2):663-9. PubMed ID: 11230353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of certain vasoactive agents on the long-term pattern of blood pressure, heart rate, and motor activity in cats.
    Brown SA; Langford K; Tarver S
    Am J Vet Res; 1997 Jun; 58(6):647-52. PubMed ID: 9185974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular actions of central neuropeptide W in conscious rats.
    Yu N; Chu C; Kunitake T; Kato K; Nakazato M; Kannan H
    Regul Pept; 2007 Feb; 138(2-3):82-6. PubMed ID: 17011641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular effects of melanin-concentrating hormone.
    Messina MM; Overton JM
    Regul Pept; 2007 Mar; 139(1-3):23-30. PubMed ID: 17045349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. State-dependent modulation of feeding behavior by proopiomelanocortin-derived beta-endorphin.
    Low MJ; Hayward MD; Appleyard SM; Rubinstein M
    Ann N Y Acad Sci; 2003 Jun; 994():192-201. PubMed ID: 12851316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute injection of ASP in the third ventricle inhibits food intake and locomotor activity in rats.
    Roy C; Roy MC; Gauvreau D; Poulin AM; Tom FQ; Timofeeva E; Richard D; Cianflone K
    Am J Physiol Endocrinol Metab; 2011 Jul; 301(1):E232-41. PubMed ID: 21540449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.